   #[1]DiabetesPro - Breaking News [RSS]

   [tr?id=1630530450548480&ev=PageView&noscript=1]

   [ajax-loader_large.gif]

   | [2]Diabetes.org | [3]About Us | [4]Join ADA | [5]Online Store |
   [6]Contact Us |

   [All ADA Resources________________]

   ____________________ (BUTTON)

   (BUTTON)

   For results that have...

   All these words: ____________________

   This exact word or phrase: ____________________

   One or more of these words: ____________________

   But don't include...

   Any of these unwanted words: ____________________

   For results that have...

   But don't include...

   All these words: ____________________

   Any of these unwanted words: ____________________

   This exact word or phrase: ____________________

   One or more of these words: ____________________

     * [7]Home
     * [8]Clinical Corner
          + [9]Clinical Practice Recommendations
          + [10]ADA Journals
          + [11]Membership
          + [12]Books for Professionals
          + [13]Patient Education Library
          + [14]Prevention Resources
          + [15]Estimated Average Glucose
          + [16]ConnecT2Day
     * [17]Diabetes Education
          + [18]Education Recognition Program
          + [19]ADA Journals
          + [20]Membership
          + [21]Books for Professionals
          + [22]Continuing Education
          + [23]Prevention Resources
          + [24]ConnecT2Day
     * [25]Research & Grants
          + [26]Funding Opportunities
          + [27]Award Administration
          + [28]DiabetesPro Quarterly
          + [29]ADA Journals
          + [30]Membership
          + [31]ADA-Funded Research
          + [32]Scientific Sessions
          + [33]Meeting Abstracts
          + [34]Meeting Posters
     * [35]Membership
          + [36]Benefits
          + [37]Interest Groups
          + [38]DiabetesPro Quarterly
          + [39]Member Directory
          + [40]Contact Us
          + [41]Books for Professionals
     * [42]Continuing Education & Meetings
          + [43]Scientific Sessions
          + [44]Annual Postgraduate Course
          + [45]Annual Clinical Conference
          + [46]Other Live Programs
          + [47]Webcasts
          + [48]Online Self Assessment Programs
          + [49]Online Performance Improvement
          + [50]Diabetes Insight Audio CME Program
          + [51]Point of Care Searching and Learning
          + [52]Other Opportunities

Abstract

   Click to add/remove this article to your list of 'My Favorites'
   Linagliptin Provides Superior Glycemic Control Compared to Voglibose as
   Monotherapy in Japanese Patients with Type 2 Diabetes

   Year: [53]2010

   Abstract Number: 632-P

   Authors: RYUZO KAWAMORI, NOBUYA INAGAKI, EIICHI ARAKI, HIROTAKA WATADA,
   NAOYUKI HAYASHI, YOSHIHARU HORIE, AKIKO SARASHINA, HANS-JUERGEN WOERLE,
   KLAUS DUGI

   Institutions: Tokyo, Japan, Kyoto, Japan, Kumamoto, Japan, Biberach,
   Germany, Ingelheim, Germany

   Results: This multi-center, 26-wk, randomized, double-blind,
   active-controlled, parallel group study, compared the efficacy and
   safety of the DPP-4 inhibitor linagliptin (LI) vs. the α-glucosidase
   inhibitor voglibose (VB) in drug naïve or previously treated Japanese
   patients (pts) with T2DM (baseline HbA[1c] 7.0-10.0% if drug naïve,
   7.0-9.0% if previously treated with an oral hypoglycemic agent (OHA)).
   Following a 2-wk PBO run-in, pts were randomized to LI 5 (n=159) or 10
   mg qd (n=160), or VB (0.2 mg tid; n=162). Any previous OHA treatment
   was stopped 2 wks prior to run-in. Mean baseline [SD] characteristics
   and demographics (HbA[1c], 8.01% [0.68]; fasting plasma glucose (FPG),
   163.5 mg/dL [32.4]; BMI, 24.97 kg/m^2 [3.86]; age, 60.0 yrs [9.7]) were
   similar across groups. The primary endpoint was the change from
   baseline in HbA[1c] after 26 wks. The differences of adjusted mean
   changes from baseline in HbA[1c] at wk 26 were -0.32% for LI 5 mg vs.
   VB (p=0.0003) and -0.39% for LI 10 mg vs. VB (p<0.0001). Proportions of
   pts achieving HbA[1c] <7.0% after 26 wks were 30.2% for LI 5 mg and
   34.4% for LI 10 mg vs. 22.2% for VB. Proportions of patients whose
   HbA[1c] level lowered by ≥0.5% were 57.2 and 53.5% for LI 5 and 10 mg,
   vs. 37.7% for VB. FPG was significantly improved with both LI 5 and 10
   mg compared to VB: the differences of adjusted mean changes from
   baseline were -6.9 mg/dL for LI 5 mg vs. VB (p=0.02) and -9.8 mg/dL for
   LI 10 mg vs. VB (p=0.0015). The occurrence of ≥1 adverse event (AE) was
   comparable between groups (72.3% LI 5 mg, 77.5% LI 10 mg and 71.6% VB).
   Of the AEs, 11.3%, 10.6% and 18.5%, respectively, were assessed as
   drug-related. There were more skin and subcutaneous tissue AEs in LI
   pts (8.2% 5 mg, 5.6% 10 mg) vs. VB pts (2.5%). Drug-related
   gastrointestinal disorders were more common in the VB (14.2%) than LI
   (8.2% 5 mg; 8.1% 10 mg) groups. In the VB group, 1 hypoglycemic episode
   was reported vs. none in the LI groups. Conclusion: LI monotherapy
   demonstrated greater efficacy than VB for improving glycemic control in
   Japanese pts with T2DM and was well tolerated in this population.

   Category: [54]Pharmacologic Treatment of Diabetes or its Complications

   Follow us on [55]Twitter, [56]Facebook, and [57]YouTube
   [58]Twitter [59]Facebook [60]YouTube
     * [61]My Favorites
     * [62]For Media
     * [63]Careers at ADA
     * [64]Privacy Policy
     * [65]Terms of Use

   American Diabetes Association 1701 North Beauregard Street Alexandria,
   VA 22311 1-800-DIABETES

References

   Visible links
   1. http://professional.diabetes.org/content/rss/rss_breakingnews.xml
   2. http://www.diabetes.org/
   3. http://www.diabetes.org/about-us/
   4. http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=64575
   5. http://shopdiabetes.org/Categories/3-Health-Care-Professional.aspx
   6. http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=84038
   7. http://professional.diabetes.org/Default.aspx
   8. http://professional.diabetes.org/HomeClinicalCorner.aspx?hsid=1
   9. http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=84160
  10. http://professional.diabetes.org/Journals_search.aspx
  11. http://professional.diabetes.org/HomeMembership.aspx?hsid=3
  12. http://www.shopdiabetes.org/professional-titles.aspx
  13. http://professional.diabetes.org/PatientEducationLibrary.aspx
  14. http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=60379
  15. http://professional.diabetes.org/eag
  16. http://professional.diabetes.org/ConnecT2Day_Home.aspx
  17. http://professional.diabetes.org/HomeDiabetesEducationAndRecognition.aspx?hsid=4
  18. http://professional.diabetes.org/HomeDiabetesEducationAndRecognition.aspx?hsid=4
  19. http://professional.diabetes.org/Journals_search.aspx
  20. http://professional.diabetes.org/HomeMembership.aspx?hsid=3
  21. http://www.shopdiabetes.org/professional-titles.aspx
  22. http://professional.diabetes.org/HomeContinuingEducationAndMeetings.aspx?hsid=5
  23. http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=60379
  24. http://professional.diabetes.org/ConnecT2Day_Home.aspx
  25. http://professional.diabetes.org/HomeResearchGrantsAndFunding.aspx?hsid=2
  26. http://professional.diabetes.org/HomeResearchGrantsAndFunding.aspx?hsid=2
  27. http://professional.diabetes.org/Diabetes_Research.aspx?typ=18&cid=91960
  28. http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=61039
  29. http://professional.diabetes.org/Journals_search.aspx
  30. http://professional.diabetes.org/HomeMembership.aspx?hsid=3
  31. http://professional.diabetes.org/Diabetes_Research.aspx?typ=18&cid=96136
  32. http://ScientificSessions.diabetes.org/
  33. http://professional.diabetes.org/Abstracts_Search.aspx
  34. http://professional.diabetes.org/Posters_Search.aspx
  35. http://professional.diabetes.org/HomeMembership.aspx?hsid=3
  36. http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=64575
  37. http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=71422
  38. http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=61039
  39. http://professional.diabetes.org/directory
  40. http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=89361
  41. http://www.shopdiabetes.org/professional-titles.aspx
  42. http://professional.diabetes.org/HomeContinuingEducationAndMeetings.aspx?hsid=5
  43. http://scientificsessions.diabetes.org/
  44. http://professional.diabetes.org/pg
  45. http://professional.diabetes.org/acc
  46. http://professional.diabetes.org/Congress_Display.aspx?TYP=9&SID=771&CID=71060
  47. http://professional.diabetes.org/Congress_Display.aspx?TYP=9&SID=772&CID=71060
  48. http://professional.diabetes.org/Congress_Display.aspx?TYP=9&SID=773&CID=71060
  49. http://w3.nethealth.co/ada/pim/
  50. http://www.audio-digest.org/CME-Subscription/diabetes-insight
  51. http://professional.diabetes.org/poc_learnmore.aspx
  52. http://professional.diabetes.org/Congress_Display.aspx?TYP=9&SID=775&CID=71060
  53. http://professional.diabetes.org/Presentations_Details.aspx?meeting=116&cng=116&typ=1
  54. http://professional.diabetes.org/Abstracts_byCategory.aspx?ID=253&Cat=Pharmacologic Treatment of Diabetes or its Complications
  55. http://www.twitter.com/ADA_diabetespro
  56. http://www.facebook.com/DiabetesPro
  57. http://www.youtube.com/user/AmericanDiabetesAssn?&utm_source=WWW&utm_medium=SocialMedia&utm_campaign=YT
  58. http://www.twitter.com/ADA_diabetespro
  59. http://www.facebook.com/DiabetesPro
  60. http://www.youtube.com/user/AmericanDiabetesAssn?&utm_source=WWW&utm_medium=SocialMedia&utm_campaign=YT
  61. http://professional.diabetes.org/Favorites.aspx
  62. http://www.diabetes.org/for-media/?WTLPromo=FOOTER_formedia
  63. http://careers.diabetes.org/?WTLPromo=FOOTER_careers
  64. http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=84039
  65. http://www.diabetes.org/about-us/terms-of-use.html?WTLPromo=FOOTER_termsofuse

   Hidden links:
  67. http://professional.diabetes.org/Default.aspx
  68. http://professional.diabetes.org/Abstracts_Display.aspx?CID=79579
